Autoantibodies that drive extraintestinal manifestations of gluten-related disorders are developed in the gut
Coeliac disease is reported to affect around 1% of the western population, with ingestion of gluten typically initiating inflammation of the bowel. Current diagnostic assays based on biomarkers of gluten sensitivity are only specific for patients with classical gastrointestinal symptoms, such as tho...
| Main Author: | |
|---|---|
| Published: |
Cardiff University
2017
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.716071 |